Skip to main content
    B

    BeOne Medicines AG (ONC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $413.26
    +1.97 (+0.48%)

    Market Cap: $46.98B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    BeOne Medicines AG (ONC) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    BeOne Medicines AG (ONC) has a market cap of $46.98B. Its return on invested capital of 7.51% compares with a 4.83% median across 9 similar companies.

    Total Valuation

    Market Cap$46.98B
    Latest price (Nov 17, 2026)$413.26

    Key Dates

    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 1.30% in the quarter ended Sep 30, 2026 and grew 5.85% a year over 2 years.

    Shares Outstanding117.30M
    Shares Change (YoY)+2.43%
    Shares Change (QoQ)+1.30%
    Share Count Growth (2Y CAGR)+5.85%

    Valuation Ratios

    Sales and book value multiples are 18.8x and 8.3x.

    P/E Ratio50.2x
    P/S Ratio18.8x
    P/B Ratio8.3x
    P/FCF Ratio83.6x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 73.6x EBITDA and 75.5x free cash flow.

    EV / EBITDA73.6x
    EV / FCF75.5x

    Price Statistics

    The stock is up 12.97% over 52 weeks and trades 11.25% above its 50-day average.

    Beta (1Y)0.67
    52-Week Change+12.97%
    1-Month Change+11.64%
    3-Month Change+9.66%
    6-Month Change+39.14%
    5-Year Change+3.53%
    10-Year Change+1014.11%
    Total Return (1Y)+12.97%
    Total Return (3Y CAGR)+30.27%
    Total Return (5Y CAGR)+2.29%
    Return vs SPY (1Y)+2.00%
    Max Drawdown (1Y)-30.89%
    Max Drawdown (3Y)-31.06%
    Sharpe Ratio (1Y)0.38
    Correlation with SPY (1Y)0.27
    50-Day Average$371.47
    200-Day Average$328.49
    52-Week Range$253.95 to $424.73
    RSI (14 Days)64.5
    Average Volume (20 Days)451.39K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 3.55x current liabilities, and total debt is 0.18x shareholder equity.

    Current Ratio3.55x
    Quick Ratio3.19x
    Debt / Equity0.18x
    Debt / EBITDA1.81x
    Interest Coverage9.41x

    Returns and Efficiency

    Return on invested capital is 7.51% over the last 12 months, against a 5-year average of -15.50%.

    Return on Assets (ROA)4.68%
    Return on Invested Capital (ROIC)7.51%
    ROIC (5Y Average)-15.50%
    Inventory Turnover0.63x
    Receivables Turnover3.94x
    Cash Conversion Cycle315 days

    Scores

    ONC has an Altman Z-Score of 7.26, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.

    Altman Z-Score7.26
    Altman Z ZoneSafe
    Piotroski F-Score7 of 9
    Piotroski StrengthAverage

    Dividends and Yields

    ONC does not pay a dividend. Its free cash flow yield is 1.20%.

    Earnings Yield1.99%
    FCF Yield1.20%

    Peer Position

    Against 7 similar companies, ONC has the 2nd highest P/E.

    P/E Ratio50.2x vs 29.8x median
    P/S Ratio18.8x vs 13.8x median
    ROIC7.51% vs 4.83% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About ONC

    What is ONC's market cap?

    BeOne Medicines AG has a market cap of $46.98B.

    What is ONC's P/E ratio?

    BeOne Medicines AG has a trailing P/E ratio of 50.2x.

    How many shares of ONC are outstanding?

    BeOne Medicines AG has 117.30M shares outstanding. The count is up 2.43% from a year earlier.

    Does ONC pay a dividend?

    No. BeOne Medicines AG does not pay a dividend.